Oslo - Delayed Quote NOK
Oncoinvent ASA (ONCIN.OL)
1.6060
+0.0160
+(1.01%)
At close: May 16 at 4:16:32 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -1.23 | -1.18 |
| Low Estimate | 0 | 0 | -1.23 | -1.18 |
| High Estimate | 0 | 0 | -1.23 | -1.18 |
| Year Ago EPS | -- | -- | -1.52 | -1.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 13.14M | 6.32M |
| Low Estimate | -- | -- | 13.14M | 6.32M |
| High Estimate | -- | -- | 13.14M | 6.32M |
| Year Ago Sales | -- | -- | 8.1M | 13.14M |
| Sales Growth (year/est) | -- | -- | 62.14% | -51.89% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.23 | -1.18 |
| 7 Days Ago | 0 | 0 | -1.23 | -1.18 |
| 30 Days Ago | 0 | 0 | -1.23 | -1.18 |
| 60 Days Ago | 0 | 0 | -1.23 | -1.18 |
| 90 Days Ago | 0 | 0 | -1.23 | -1.18 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ONCIN.OL | -- | -- | 19.06% | 3.93% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Related Tickers
ZLNA.OL Zelluna ASA
13.75
-1.06%
ABS.OL Arctic Bioscience AS
3.8500
+4.05%
CRNA.OL Circio Holding ASA
0.6270
-4.27%
PCIB.OL PCI Biotech Holding ASA
1.7600
-5.38%
LYTIX.OL Lytix Biopharma AS
7.60
-1.30%
BGBIO.OL BerGenBio ASA
1.7500
+2.58%
HURA TuHURA Biosciences, Inc.
3.9200
+2.08%
VRCA Verrica Pharmaceuticals Inc.
0.6623
+3.19%
VSTM Verastem, Inc.
7.59
-4.29%